106 related articles for article (PubMed ID: 9492315)
1. Modulation of DNA-protein interactions in the P1 and P2 c-myc promoters by two intercalating drugs.
Vaquero A; Portugal J
Eur J Biochem; 1998 Jan; 251(1-2):435-42. PubMed ID: 9492315
[TBL] [Abstract][Full Text] [Related]
2. Abortive transcription of the T7 promoter induced by elsamicin A.
Portugal J
Anticancer Drug Des; 1995 Jul; 10(5):427-38. PubMed ID: 7639931
[TBL] [Abstract][Full Text] [Related]
3. FOXM1c and Sp1 transactivate the P1 and P2 promoters of human c-myc synergistically.
Wierstra I; Alves J
Biochem Biophys Res Commun; 2007 Jan; 352(1):61-8. PubMed ID: 17141659
[TBL] [Abstract][Full Text] [Related]
4. Mithramycin blocks transcriptional initiation of the c-myc P1 and P2 promoters.
Snyder RC; Ray R; Blume S; Miller DM
Biochemistry; 1991 Apr; 30(17):4290-7. PubMed ID: 1827033
[TBL] [Abstract][Full Text] [Related]
5. Chartreusin, elsamicin A and related anti-cancer antibiotics.
Portugal J
Curr Med Chem Anticancer Agents; 2003 Nov; 3(6):411-20. PubMed ID: 14529449
[TBL] [Abstract][Full Text] [Related]
6. c-Myc and Sp1/3 are required for transactivation of hamster telomerase catalytic subunit gene promoter.
Park NH; Guo W; Kim HR; Kang MK; Park NH
Int J Oncol; 2001 Oct; 19(4):755-61. PubMed ID: 11562751
[TBL] [Abstract][Full Text] [Related]
7. Repeated CT elements bound by zinc finger proteins control the absolute and relative activities of the two principal human c-myc promoters.
DesJardins E; Hay N
Mol Cell Biol; 1993 Sep; 13(9):5710-24. PubMed ID: 8355712
[TBL] [Abstract][Full Text] [Related]
8. Novel clustering of Sp1 transcription factor binding sites at the transcription initiation site of the human muscle phosphofructokinase P1 promoter.
Johnson JL; McLachlan A
Nucleic Acids Res; 1994 Nov; 22(23):5085-92. PubMed ID: 7800504
[TBL] [Abstract][Full Text] [Related]
9. Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT).
Kyo S; Takakura M; Taira T; Kanaya T; Itoh H; Yutsudo M; Ariga H; Inoue M
Nucleic Acids Res; 2000 Feb; 28(3):669-77. PubMed ID: 10637317
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoid regulation of c-myc promoter utilization in P1798 T-lymphoma cells.
Ma T; Mahajan PB; Thompson EA
Mol Endocrinol; 1992 Jun; 6(6):960-8. PubMed ID: 1495494
[TBL] [Abstract][Full Text] [Related]
11. Differential transcriptional regulation of c-myc promoter through the same DNA binding sites targeted by Sp1-like proteins.
Majello B; De Luca P; Suske G; Lania L
Oncogene; 1995 May; 10(9):1841-8. PubMed ID: 7753559
[TBL] [Abstract][Full Text] [Related]
12. Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3.
Gartel AL; Ye X; Goufman E; Shianov P; Hay N; Najmabadi F; Tyner AL
Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4510-5. PubMed ID: 11274368
[TBL] [Abstract][Full Text] [Related]
13. DNA binding and antigene activity of a daunomycin-conjugated triplex-forming oligonucleotide targeting the P2 promoter of the human c-myc gene.
Carbone GM; McGuffie E; Napoli S; Flanagan CE; Dembech C; Negri U; Arcamone F; Capobianco ML; Catapano CV
Nucleic Acids Res; 2004; 32(8):2396-410. PubMed ID: 15121897
[TBL] [Abstract][Full Text] [Related]
14. Sp1 and c-Myc regulate transcription of BMI1 in nasopharyngeal carcinoma.
Wang HB; Liu GH; Zhang H; Xing S; Hu LJ; Zhao WF; Xie B; Li MZ; Zeng BH; Li Y; Zeng MS
FEBS J; 2013 Jun; 280(12):2929-44. PubMed ID: 23601184
[TBL] [Abstract][Full Text] [Related]
15. Molecular dynamics study of the binding of elsamicin A to DNA.
Alhambra C; Luque FJ; Portugal J; Orozco M
Eur J Biochem; 1995 Jun; 230(2):555-66. PubMed ID: 7607229
[TBL] [Abstract][Full Text] [Related]
16. TATA box and Sp1 sites mediate the activation of c-myc promoter P1 by immunoglobulin kappa enhancers.
Geltinger C; Hörtnagel K; Polack A
Gene Expr; 1996; 6(2):113-27. PubMed ID: 8979089
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of in vitro transcription by a triplex-forming oligonucleotide targeted to human c-myc P2 promoter.
Kim HG; Miller DM
Biochemistry; 1995 Jun; 34(25):8165-71. PubMed ID: 7794930
[TBL] [Abstract][Full Text] [Related]
18. Two Sp sites are important cis elements regulating the upstream promoter region of the gene for rat type I hexokinase.
Liu W; Wilson JE
Arch Biochem Biophys; 1997 Oct; 346(1):142-50. PubMed ID: 9328294
[TBL] [Abstract][Full Text] [Related]
19. Detection of elsamicin-DNA binding specificity by restriction enzyme cleavage.
Párraga A; Portugal J
FEBS Lett; 1992 Mar; 300(1):25-9. PubMed ID: 1312486
[TBL] [Abstract][Full Text] [Related]
20. Xenopus laevis c-myc I and II genes: molecular structure and developmental expression.
Principaud E; Spohr G
Nucleic Acids Res; 1991 Jun; 19(11):3081-8. PubMed ID: 2057364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
